ZBTB7B inhibits glioma tumorigenicity by upregulating GPR17 and CXCL10
Authors:
Open Access
- 26 November 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 17 (11)
Abstract
The transcription factor ZBTB7B has been identified as a potential tumor suppressor through a CRISPR–Cas9-based functional screen of tumor-associated genes, as overexpression of ZBTB7B could significantly suppress tumor growth in the models of breast cancer brain metastasis, which prompted our further exploration of its inhibitory role in glioma. To elucidate the underlying mechanisms of this suppressive effect, lentiviral-mediated ZBTB7B overexpression was established in U118 and GL261 glioma cell lines, and systematic evaluation of tumorigenic capacity was performed through in vitro and xenograft assays. The results showed that ZBTB7B transcriptionally activated GPR17 expression, which suppressed protein kinase A phosphorylation, amplified mitochondrial reactive oxygen species generation, and triggered Caspase3-dependent apoptosis. Meanwhile, ZBTB7B upregulated CXCL10 secretion, which markedly enhanced CD4+ and CD8+ T cell accumulation. Clinical validation through multiplex immunofluorescence staining on a tissue microarray of 129 glioma samples revealed a progressive loss of ZBTB7B protein expression across WHO grades II to IV, inversely correlating with tumor malignancy. These findings demonstrate ZBTB7B as a dual-function tumor suppressor that concurrently induces intrinsic apoptosis and remodels the tumor immune microenvironment in glioma toward a ‘hot’ phenotype. Therefore, we propose ZBTB7B reactivation as a novel therapeutic strategy for glioma.Keywords
This publication has 67 references indexed in Scilit:
- The Role of ThPOK in Control of CD4/CD8 Lineage CommitmentAnnual Review of Immunology, 2010
- Runx and ThPOK: A balancing act to regulate thymocyte lineage commitmentJournal of Cellular Biochemistry, 2009
- CD4-CD8 Lineage Commitment Is Regulated by a Silencer Element at the ThPOK Transcription-Factor LocusImmunity, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptorThe EMBO Journal, 2006
- The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitmentNature, 2005
- Mechanism of SMRT Corepressor Recruitment by the BCL6 BTB DomainMolecular Cell, 2003
- Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growthJournal of Neurosurgery, 2000
- BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.Proceedings of the National Academy of Sciences, 1996
- The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins.1995